NYSCF Innovator Makes Step Towards Therapies for Metabolic Diseases
NewsNYSCF – Robertson Investigator Alumna Dr. Shuibing Chen published her latest work in Cell Stem Cell creating stem cell models of type 2 diabetes in a step towards applying knowledge from genome-wide association studies to drug discovery efforts. Dr. Chen and her team at Weill Cornell Medical College created human stem cell models with genetic mutations in genes associated with the development of type 2 diabetes as identified through genome-wide association studies.
These stem cell models allow scientists to further interrogate the genes in question without harming patients, paving the way for precision therapy for metabolic diseases including type 2 diabetes.